Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Germany Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2026

Published by Inkwood Research Product code 1018669
Published Content info 144 Pages
Delivery time: 2-3 business days
Price
Back to Top
Germany Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2026
Published: July 19, 2021 Content info: 144 Pages
Description

KEY FINDINGS

The Germany sleep apnea therapeutics and diagnostics market is set to register a CAGR of 6.47% during the forecast period, 2021-2026. The market growth is primarily driven by the presence of several respiratory care medical device companies and the high healthcare expenditure.

MARKET INSIGHTS

If left untreated, sleep-wake disorders like obstructive sleep apnea and insomnia can lead to severe health problems. One of the most common devices for sleep apnea treatment is continuous positive airway pressure. Germany is home to prominent sleep apnea devices companies like Itamar Medical Ltd, ResMed Inc, Medtronic PLC, Koninklijke Philips NV, etc. Also, the country is witnessing growing side-effects of urban lifestyle like diabetes, anxiety, technological advancements, and obesity, and a high prevalence of obstructive sleep apnea.

Due to the pandemic, the clinical testing of sleep apnea has been suspended. As per the European Respiratory Journal study on sleep apnea management during the pandemic in 2020, the clinical PSG testing number decreased to 20% from 92.5% across the sleep centers in Europe, including German Sleep Society Center. Moreover, teleconsultation has dipped from 30% to 27.5%. Such aspects constitute the German sleep apnea market.

COMPETITIVE INSIGHTS

Some of the eminent companies in the market are: GE Healthcare, Somnomedics GmbH, Invacare Corporation, Koninklijke Philips NV, Medtronic Plc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 38122

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. KEY GROWTH ENABLERS
  • 2.5. KEY CHALLENGES

3. KEY ANALYTICS

  • 3.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • 3.2. KEY MARKET TRENDS
  • 3.3. PORTER'S FIVE FORCES ANALYSIS
    • 3.3.1. BUYERS POWER
    • 3.3.2. SUPPLIERS POWER
    • 3.3.3. SUBSTITUTION
    • 3.3.4. NEW ENTRANTS
    • 3.3.5. INDUSTRY RIVALRY
  • 3.4. REGULATORY FRAMEWORK
  • 3.5. SUPPLY CHAIN ANALYSIS
  • 3.6. OPPORTUNITY MATRIX
  • 3.7. VENDOR LANDSCAPE

4. MARKET BY PRODUCT TYPE

  • 4.1. THERAPEUTICS
    • 4.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
    • 4.1.2. OXYGEN DEVICES
    • 4.1.3. MASKS AND ACCESSORIES
    • 4.1.4. ORAL APPLIANCES
    • 4.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
  • 4.2. DIAGNOSTICS AND MONITORING
    • 4.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
    • 4.2.2. OXIMETER
    • 4.2.3. ACTIGRAPHY MONITORING DEVICE
    • 4.2.4. RESPIRATORY POLYGRAPH
    • 4.2.5. SLEEP APNEA SCREENING DEVICE
    • 4.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES

5. MARKET BY END-USER

  • 5.1. HOSPITALS & SLEEP LABORATORIES
  • 5.2. HOME CARE SETTINGS

6. COMPETITIVE LANDSCAPE

  • 6.1. KEY STRATEGIC DEVELOPMENTS
    • 6.1.1. MERGERS & ACQUISITIONS
    • 6.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 6.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
    • 6.1.4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
  • 6.2. COMPANY PROFILES
    • 6.2.1. GE HEALTHCARE
    • 6.2.2. INVACARE CORPORATION
    • 6.2.3. MEDTRONIC PLC
    • 6.2.4. KONINKLIJKE PHILIPS NV
    • 6.2.5. SOMNOMEDICS GMBH

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
  • TABLE 2: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 4: GERMANY THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GERMANY THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 6: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 8: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 10: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2026 (IN $ MILLION)
  • TABLE 12: LEADING PLAYERS OPERATING IN GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 13: LIST OF MERGERS & ACQUISITIONS
  • TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • TABLE 16: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS

LIST OF FIGURES

  • FIGURE 1: ADVANTAGES OF PORTABLE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS, 2021-2026 (IN $ MILLION)
  • FIGURE 7: GERMANY SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2021-2026 (IN $ MILLION)
  • FIGURE 8: GERMANY SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES, 2021-2026 (IN $ MILLION)
  • FIGURE 9: GERMANY SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND ACCESSORIES, 2021-2026 (IN $ MILLION)
  • FIGURE 10: GERMANY SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES, 2021-2026 (IN $ MILLION)
  • FIGURE 11: GERMANY SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO VENTILATION (ASV) DEVICES, 2021-2026 (IN $ MILLION)
  • FIGURE 12: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY DIAGNOSTICS AND MONITORING, 2021-2026 (IN $ MILLION)
  • FIGURE 13: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY DEVICE (PSG), 2021-2026 (IN $ MILLION)
  • FIGURE 14: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER, 2021-2026 (IN $ MILLION)
  • FIGURE 15: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY MONITORING DEVICE, 2021-2026 (IN $ MILLION)
  • FIGURE 16: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY POLYGRAPH, 2021-2026 (IN $ MILLION)
  • FIGURE 17: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA SCREENING DEVICE, 2021-2026 (IN $ MILLION)
  • FIGURE 18: GERMANY DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS AND MONITORING DEVICES, 2021-2026 (IN $ MILLION)
  • FIGURE 19: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, IN 2020
  • FIGURE 20: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOSPITALS & SLEEP LABORATORIES, 2021-2026 (IN $ MILLION)
  • FIGURE 21: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOME CARE SETTINGS, 2021-2026 (IN $ MILLION)
Back to Top